Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Depreciation & Amortization (CF) (2016 - 2025)

Skinvisible (SKVI) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $5118.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 1.35% to $5118.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20239.0 through Dec 2025, down 0.97% year-over-year, with the annual reading at $20239.0 for FY2025, 0.97% down from the prior year.
  • Depreciation & Amortization (CF) hit $5118.0 in Q4 2025 for Skinvisible, roughly flat from $5118.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $5937.0 in Q3 2024 to a low of $4251.0 in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $4806.2 across 5 years, with a median of $4733.5 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 56.86% in 2021 and later skyrocketed 30.77% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $4695.0 in 2021, then grew by 0.92% to $4738.0 in 2022, then rose by 0.19% to $4747.0 in 2023, then grew by 6.38% to $5050.0 in 2024, then grew by 1.35% to $5118.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SKVI at $5118.0 in Q4 2025, $5118.0 in Q3 2025, and $5063.0 in Q2 2025.